Karl-Franzens-University Graz
About Karl-Franzens-University Graz
The University of Graz, located in Graz, Austria, is the largest and oldest university in Styria, as well as the second-largest and second-oldest university in Austria.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
8
Vertex Pharmaceuticals Incorporated
3
Intercept Pharmaceuticals
2
Allergan
1
AqueSys, Inc.
1
Collaborative Group for Adrenocortical Carcinoma Treatment
1
Galderma R&D
1
Neovasc Inc.
1
The George Institute
1
VITATOPS
1
Clinical Trials at Karl-Franzens-University Graz
During the past decade, Karl-Franzens-University Graz conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
1995-02-01
2012-06-01
Completed
350
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
1998-09-01
Completed
704
Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
2002-06-01
Completed
36
Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer
2002-03-01
Unknown status
686
Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
2003-01-01
2011-06-01
Terminated
93
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
2003-04-01
2012-07-01
Completed
455
Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
2003-10-01
2010-09-01
Completed
49
Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
2004-03-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Karl-Franzens-University Graz" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials, followed by "Vertex Pharmaceuticals Incorporated" with 3 trials
sponsored, "Intercept Pharmaceuticals" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "AqueSys, Inc."
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Karl-Franzens-University Graz"
#1 collaborator was "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "Arbeitsgemeinschaft fur Internistische Onkologie" with 1 trials as a collaborator, "Dutch Colorectal Cancer Group (DCCG)" with 1 trials as a collaborator, "EORTC GI Group (EORTC 40023)" with 1 trials as a collaborator and "Egyptian Foundation For Cancer Research" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at Karl-Franzens-University Graz
According to Clinical.Site data, the most researched conditions in "Karl-Franzens-University Graz" are
"Cystic Fibrosis" (3 trials), "Liver Cirrhosis, Biliary" (2 trials), "Lymphoma" (2 trials), "Ovarian Cancer" (2 trials) and "Sarcoma" (2 trials). Many other conditions were trialed in "Karl-Franzens-University Graz" in a lesser frequency.
Clinical Trials Intervention Types at Karl-Franzens-University Graz
Most popular intervention types in "Karl-Franzens-University Graz" are "Drug" (16 trials), "Procedure" (9 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "IVA" (3 trials), "adjuvant therapy" (3 trials), "conventional surgery" (3 trials) and "cisplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Karl-Franzens-University Graz
The vast majority of trials in "Karl-Franzens-University Graz" are
18 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Karl-Franzens-University Graz
Currently, there are NaN active trials in "Karl-Franzens-University Graz".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in Karl-Franzens-University Graz,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Karl-Franzens-University Graz, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".